AMT 151
Alternative Names: AMT-151Latest Information Update: 28 Jul 2026
At a glance
- Originator Multitude Therapeutics
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Non-small cell lung cancer; Ovarian cancer; Solid tumours; Triple negative breast cancer
Most Recent Events
- 28 Jul 2026 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in USA (Parenteral)
- 28 Jul 2026 No recent reports of development identified for preclinical development in Ovarian-cancer in USA (Parenteral)
- 28 Jul 2026 No recent reports of development identified for preclinical development in Solid-tumours in USA (Parenteral)